Virologica Sinica

, Volume 32, Issue 6, pp 503–510 | Cite as

Hepatitis C virus-induced prion protein expression facilitates hepatitis C virus replication

  • Huixia Zhang
  • Shanshan Gao
  • Rongjuan Pei
  • Xinwen Chen
  • Chaoyang LiEmail author
Research Article


Hepatitis C virus (HCV) infects approximately 180 million people worldwide. Significant progress has been made since the establishment of in vitro HCV infection models in cells. However, the replication of HCV is complex and not completely understood. Here, we found that the expression of host prion protein (PrP) was induced in an HCV replication cell model. We then showed that increased PrP expression facilitated HCV genomic replication. Finally, we demonstrated that the KKRPK motif on the N-terminus of PrP bound nucleic acids and facilitated HCV genomic replication. Our results provided important insights into how viruses may harness cellular protein to achieve propagation.


hepatitis C virus (HCV) NS3 NS5B prion protein (PrP) 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



This work was supported by the Strategic Priority Research Program A of the Chinese Academy of Sciences (XDA12010309), the National Science Foundation of China (31670170), the Nature Science Foundation of Hubei Province (2015CFA087), and the National Basic Research Priorities Program of China (2013CB911102). We thank the Core Facility and Technical Support, Wuhan Institute of Virology for assistance with confocal micros copy (Dr. Ding Gao) and flow cytometry (Ms. Juan Min).

Supplementary material

12250_2017_4039_MOESM1_ESM.pdf (111 kb)
Hepatitis C virus-induced prion protein expression facilitates hepatitis C virus replication


  1. Alais S, Soto-Rifo R, Balter V, Gruffat H, Manet E, Schaeffer L, Darlix JL, Cimarelli A, Raposo G, Ohlmann T. 2012. Functional mechanisms of the cellular prion protein (prpc) associated anti-HIV-1 properties. Cell Mol Life Sci, 69: 1331–1352.CrossRefPubMedGoogle Scholar
  2. Benestad SL, Austbø L, Tranulis MA, Espenes A, Olsaker I. 2012. Healthy goats naturally devoid of prion protein. Vet Res, 43: 87.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Blight KJ, McKeating JA, Rice CM. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol, 76: 13001–13014.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Bounhar Y, Zhang Y, Goodyer CG, LeBlanc A. 2001. Prion protein protects human neurons against Bax-mediated apoptosis. J Biol Chem, 276: 39145–39149.CrossRefPubMedGoogle Scholar
  5. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, von Bohlen A, Schulz-Schaeffer W. 1997. The cellular prion protein binds copper in vivo. Nature, 390: 684–687.CrossRefPubMedGoogle Scholar
  6. Caruso P, Burla R, Piersanti S, Cherubini G, Remoli C, Martina Y, Saggio I. 2009. Prion expression is activated by adenovirus 5 infection and affects the adenoviral cycle in human cells. Virology, 385: 343–350.CrossRefPubMedGoogle Scholar
  7. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244: 359–362.CrossRefPubMedGoogle Scholar
  8. Collins JM, Raphael KL, Terry C, Cartwright EJ, Pillai A, Anania FA, Farley MM. 2015. Hepatitis B virus reactivation during successful treatment of hepatitis C virus with sofosbuvir and simeprevir. Clin Infect Dis, 61: 1304–1306.CrossRefPubMedGoogle Scholar
  9. Ende AR, Kim NH, Yeh MM, Harper J, Landis CS. 2015. Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: A case report. J Med Case Rep, 9: 164.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Friebe P, Boudet J, Simorre JP, Bartenschlager R. 2005. Kissingloop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication. J Virol, 79: 380–392.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Gabus C, Auxilien S, Péchoux C, Dormont D, Swietnicki W, Morillas M, Surewicz W, Nandi P, Darlix JL. 2001a. The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. J Mol Biol, 307: 1011–1021.CrossRefPubMedGoogle Scholar
  12. Gabus C, Derrington E, Leblanc P, Chnaiderman J, Dormont D, Swietnicki W, Morillas M, Surewicz WK, Marc D, Nandi P. 2001b. The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. J Biol Chem, 276: 19301–19309.CrossRefPubMedGoogle Scholar
  13. Gao Z, Zhang H, Hu F, Yang L, Yang X, Zhu Y, Sy MS, Li C. 2016. Glycan-deficient PrP stimulates VEGFR2 signaling via glycosaminoglycan. Cell Signal, 28: 652–662.CrossRefPubMedGoogle Scholar
  14. Ikeda K, Kawada N, Wang YQ, Kadoya H, Nakatani K, Sato M, Kaneda K. 1998. Expression of cellular prion protein in activated hepatic stellate cells. Am J Pathol, 153: 1695–1700.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Koutsoudakis G, Herrmann E, Kallis S, Bartenschlager R, Pietschmann T. 2007. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol, 81: 588–598.CrossRefPubMedGoogle Scholar
  16. Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Matsumoto Y, Yokoyama T, Itohara S. 1999. Prions prevent neuronal cell-line death. Nature, 400: 225–226.CrossRefPubMedGoogle Scholar
  17. Kwo P, Gane EJ, Peng C-Y, Pearlman B, Vierling JM, Serfaty L, Buti M, Shafran S, Stryszak P, Lin L. 2017. Effectiveness of elbasvir and grazoprevir combination, with or without ribavirin, for treatment-experienced patients with chronic hepatitis C infection. Gastroenterology, 152: 164–175.CrossRefPubMedGoogle Scholar
  18. Lötscher M, Recher M, Lang KS, Navarini A, Hunziker L, Santimaria R, Glatzel M, Schwarz P, Böni J, Zinkernagel RM. 2007. Induced prion protein controls immune-activated retroviruses in the mouse spleen. PLoS One, 2: e1158.CrossRefPubMedPubMedCentralGoogle Scholar
  19. Lai CK, Jeng KS, Machida K, Lai MM. 2008. Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A. J Virol, 82: 8838–8848.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Li C, Yu S, Nakamura F, Yin S, Xu J, Petrolla AA, Singh N, Tartakoff A, Abbott DW, Xin W, Sy MS. 2009. Binding of proprion to filamin a disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer. J Clin Invest, 119: 2725–2736.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Li Q, Zhang YY, Chiu S, Hu Z, Lan KH, Cha H, Sodroski C, Zhang F, Hsu CS, Thomas E, Liang TJ. 2014. Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle. PLoS Pathog, 10: e1004163.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Liu T, Li R, Pan T, Liu D, Petersen RB, Wong B-S, Gambetti P, Sy MS. 2002. Intercellular transfer of the cellular prion protein. J Biol Chem, 277: 47671–47678.CrossRefPubMedGoogle Scholar
  23. Lohmann V, Körner F, Koch J-O, Herian U, Theilmann L, Bartenschlager R. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science, 285: 110–113.CrossRefPubMedGoogle Scholar
  24. Müller WE, Pfeifer K, Forrest J, Rytik PG, Eremin VF, Popov SA, Schröder HC. 1992. Accumulation of transcripts coding for prion protein in human astrocytes during infection with human immunodeficiency virus. Biochim Biophys Acta, 1139: 32–40.CrossRefPubMedGoogle Scholar
  25. Ma Y, Yates J, Liang Y, Lemon SM, Yi M. 2008. NS3 helicase domains involved in infectious intracellular hepatitis c virus particle assembly. J Virol, 82: 7624–7639.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Manns MP, Cornberg M. 2013. Sofosbuvir: The final nail in the coffin for hepatitis C?. The Lancet Infect Dis, 13: 378–379.CrossRefPubMedGoogle Scholar
  27. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche J, Lehmann S, Launay J, Kellermann O. 2000. Signal transduction through prion protein. Science, 289: 1925–1928.CrossRefPubMedGoogle Scholar
  28. Nakamura Y, Sakudo A, Saeki K, Kaneko T, Matsumoto Y, Toniolo A, Itohara S, Onodera T. 2003. Transfection of prion protein gene suppresses Coxsackievirus B3 replication in prion protein gene-deficient cells. J Gen Virol, 84: 3495–3502.CrossRefPubMedGoogle Scholar
  29. Nikles D, Bach P, Boller K, Merten CA, Montrasio F, Heppner FL, Aguzzi A, Cichutek K, Kalinke U, Buchholz CJ. 2005. Circumventing tolerance to the prion protein (PrP): Vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP. J Virol, 79: 4033–4042.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Odolini S, Lanza P, Angiola A, Zaltron S, Urbinati L, Vavassori A, Nasta P, Festa E, Gargiulo F, Rodella A. 2017. Hepatitis B virus reactivation after effective sofosbuvir and ribavirin treatment in a patient with occult hepatitis B virus infection. New Microbiol, 40: 218–220.PubMedGoogle Scholar
  31. Paitel E, Fahraeus R, Checler F. 2003. Cellular prion protein sensitizes neurons to apoptotic stimuli through mdm2-regulated and p53-dependent caspase 3-like activation. J Biol Chem, 278: 10061–10066.CrossRefPubMedGoogle Scholar
  32. Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang S-L, DeArmond SJ. 1993. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A, 90: 10608–10612.CrossRefPubMedPubMedCentralGoogle Scholar
  33. Richt JA, Kasinathan P, Hamir AN, Castilla J, Sathiyaseelan T, Vargas F, Sathiyaseelan J, Wu H, Matsushita H, Koster J. 2007. Production of cattle lacking prion protein. Nat Biotechnol, 25: 132–138.CrossRefPubMedGoogle Scholar
  34. Sailer A, Büeler H, Fischer M, Aguzzi A, Weissmann C. 1994. No propagation of prions in mice devoid of PrP. Cell, 77: 967–968.CrossRefPubMedGoogle Scholar
  35. Sakamoto N, Watanabe M. 2009. New therapeutic approaches to hepatitis C virus. J Gastroenterol, 44: 643.CrossRefPubMedGoogle Scholar
  36. Simister P, Schmitt M, Geitmann M, Wicht O, Danielson UH, Klein R, Bressanelli S, Lohmann V. 2009. Structural and functional analysis of hepatitis C virus strain JFH1 polymerase. J Virol, 83: 11926–11939.CrossRefPubMedPubMedCentralGoogle Scholar
  37. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Kräusslich H-G, Mizokami M. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med, 11: 791–796.CrossRefPubMedPubMedCentralGoogle Scholar
  38. Yamashita T, Kaneko S, Shirota Y, Qin W, Nomura T, Kobayashi K, Murakami S. 1998. RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the c-terminal region. J Biol Chem, 273: 15479–15486.CrossRefPubMedGoogle Scholar
  39. Yang L, Zhang Y, Hu L, Zhu Y, Sy MS, Li C. 2014. A panel of monoclonal antibodies against the prion protein proves that there is no prion protein in human pancreatic ductal epithelial cells. Virol Sin, 29: 228–236.CrossRefPubMedGoogle Scholar
  40. Yang L, Gao Z, Hu L, Wu G, Yang X, Zhang L, Zhu Y, Wong BS, Xin W, Sy MS. 2016. Glycosylphosphatidylinositol anchor modification machinery deficiency is responsible for the formation of pro-prion protein (PrP) in Bxpc-3 protein and increases cancer cell motility. J Biol Chem, 291: 3905–3917.CrossRefPubMedGoogle Scholar
  41. Yang X, Zhang Y, Zhang L, He T, Zhang J, Li C. 2014. Prion protein and cancers. Acta Biochim Biophys Sin (Shanghai), 46: 431–440.CrossRefGoogle Scholar
  42. Zanusso G, Liu D, Ferrari S, Hegyi I, Yin X, Aguzzi A, Hornemann S, Liemann S, Glockshuber R, Manson JC. 1998. Prion protein expression in different species: Analysis with a panel of new mabs. Proc Natl Acad Sci U S A, 95: 8812–8816.CrossRefPubMedPubMedCentralGoogle Scholar
  43. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV. 2005. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A, 102: 9294–9299.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Wuhan Institute of Virology, CAS and Springer Nature Singapore Pte Ltd. 2017

Authors and Affiliations

  1. 1.State Key Laboratory of VirologyChinese Academy of SciencesWuhanChina
  2. 2.Center for Molecular Virology, Wuhan Institute of VirologyChinese Academy of SciencesWuhanChina
  3. 3.University of the Chinese Academy of SciencesBeijingChina

Personalised recommendations